Key result
FGF23 administration nearly quadruples AF duration and increases inducibility in mice.
Why the study?
FGF23 is associated with AF, but whether it modulates sodium and calcium currents in atrial myocytes remains unclear.
Does FGF23 increase atrial fibrillation susceptibility in mice?
Does FGF23 increase atrial fibrillation susceptibility in mice?
Answers are grounded in this paper and cite their sources.
FGF23 promotes atrial fibrillation susceptibility by inducing coordinated electrical and calcium handling abnormalities.
Fibroblast growth factor 23 (FGF23) is closely associated with atrial fibrillation (AF), yet whether it modulates sodium and calcium currents in atrial myocytes remains unclear. ETV1, a key transcription factor regulating atrial electrical conduction, may also be involved in FGF23-mediated AF. In this study, FGF23 intervention models were established via tail vein injection in mice and direct administration in vitro. ETV1 knockdown and overexpression were achieved in vitro using lentiviral vectors, and ETV1 knockout mice were generated. Patch-clamp electrophysiology, calcium imaging, and Western blotting were performed to assess electrophysiological properties and AF susceptibility. Functionally, FGF23 increased both peak and late sodium currents, while also enhancing L-type calcium current, prolonging action potential duration, and promoting early and delayed afterdepolarizations. Consistent with these electrophysiological changes, Nav1.5 and RyR2 expression levels were upregulated, accompanied by increased intracellular calcium release, thereby leading to increased AF susceptibility. In mechanistic analyses, ETV1 knockdown attenuated FGF23-induced increases in sodium current and action potential parameters but did not reduce AF susceptibility, whereas ETV1 knockout increased AF inducibility. These findings suggest that FGF23 promotes AF by inducing coordinated electrical and calcium handling abnormalities that facilitate triggered activity, while ETV1 acts as a downstream effector mediating FGF23-induced sodium channel regulation.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied Atrial fibrillation (preclinical model). FGF23 vs. PBS was evaluated on Atrial fibrillation duration (p=<0.01). FGF23 administration significantly prolonged atrial fibrillation duration (38.28 vs 9.88 seconds, p<0.01) and increased AF inducibility in mice compared to PBS control.
Synapse has enriched 10 related papers. Consider them for comparative context: